Resumption of Anticoagulation in Patients with Gastrointestinal Bleeding: A Look into the If and When

Non-interventional prospective study of all patients in our hospital who were admitted for GI bleeding while on anticoagulation in 2022. The primary outcomes were GI bleeding events, thrombotic events and mortality events within 90 days. We ran a logistic regression analysis to assess correlation between resumption of anticoagulation and primary outcomes. We ran a Mantel-Haenszel analysis between primary outcomes, various bleeding scores to determine a safe timing of resumption in our patient population.